Al-Hajj et al, enriched a CD44+/CD24−/low cell population from human breast cancer that displayed cancer stem/progenitor cell properties and was capable of forming tumors in immuno-compromised mice with higher efficiency than cells with alternative phenotypes [1]. This evidence concerns the gene CD44 and breast cancer.